Lung cancer is among the most common types of cancers prevailing all over the world. A new study by Tulane University has found a molecular pathway to stop lung cancer spread. The…
Tag: Treatment Options For Lung Cancer
Durvalumab for Treatment of Lung Cancer
Durvalumab is a type of immunotherapy and is known by its brand name, Imfinzi. Its role in treatment of small cell lung cancer is increasing. Durvalumab injection is injected into a vein…
Stereotactic Ablative Radiotherapy (SABR) For Lung Cancer
In lung cancer treatment, Stereotactic Ablative Radiotherapy (SABR) is rapidly been used as an important radiation tool. SABR is being evaluated for treatment of medically inoperable lung cancer, operable lung cancers, metastases…
Nanoparticle Vaccine Could Curb Lung Cancer Metastasis
The engineers at the University of California San Diego have come up with an experimental vaccine that could prevent the spread of metastatic cancers to the lung. The key ingredients of this…
Trial Shows Novel Vaccine’s Potential for Lung Cancer Treatment
A new vaccine has shown to improve survival rate among people suffering from lung cancer. A French biotechnology company said that Ose Immunotherapeutics’ Tedopi vaccine was effective in decreasing death risk among lung…
Tumor Treating Fields to Improve Survival Benefit in Lung Cancer
Tumor Treating Fields (TTFields) are electric fields that disrupt processes which are critical for the survival of cancer cells. This leads to immunogenic cell death and enhanced antitumor immune response. The use…
Quratusugene Ozeplasmid for Small Cell Lung Cancer Receives Orphan Drug Designation by FDA
Genprex, Inc. is a clinical-stage gene therapy company and has announced the United States Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to the drug, Reqorsa Immunogene Therapy (quratusugene…
ctDNA Testing To Reduce Time For Lung Cancer Treatment
According to the American Society of Clinical Oncology, around 2.4lac adults in the United States will be diagnosed with lung cancer of which 81% are NSCLC. Early diagnosis and treatment is one…